|
Lena Bezman, M.D., M.P.H., is a research coordinator in the Department of Neurogenetics at Kennedy Krieger Institute. She is also a research associate in the Department of Neurology at the Johns Hopkins University School of Medicine.
Biographical Sketch:
Dr. Bezman is originally from St. Petersburg, Russia. She received her MD from the Pediatric Medical Institute in St. Petersburg in 1977, where she also completed a residency in Pediatrics in 1980. She worked as a pediatrician with the Mobile Intensive Care Unit Specialized Ambulance Service and at the Premature Babies Ward Delivery Hospital, both in St. Petersburg. She was a researcher for several years at the Children’s City Hospital and became a Pediatric ICU Specialist in 1987. Dr. Bezman achieved a Master of Public Health from The Johns Hopkins University School of Hygiene and Public Health in 1992, specializing in Epidemiology. Dr. Bezman completed a fellowship with the school’s Department of Epidemiology, and was a postdoctoral fellow in clinical epidemiology. She also served as a consultant for the National Institutes of Health, the National Cancer Institute and the Ministry of Health of Belarus.
Dr. Bezman joined Kennedy Krieger Institute in 1994 as a Research Coordinator in the Department of Neurogenetics. She is also a research associate in the Department of Neurology at the Johns Hopkins University School of Medicine.
Research Summary:
Dr. Bezman’s clinical interests have recently focused on adrenoleukodystrophy, including its treatment, progression, mutation and prognosis. She also received grants to study peroxisomal disorders and the genetic causes of mental retardation.
Recent Publications/Presentations:
Moser HW, Raymond GV, Lu SE, Muenz LR, Moser AB, Xu J, Jones RO, Loes, DJ, Melhem ER, Dubey P, Bezman L, Brereton NH, Odone A. Follow-up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzo's oil. Arch Neurol. 2005 Jul;62(7):1073-80.
Dubey P, Raymond GV, Moser AB, Kharkar S, Bezman L, Moser HW. Adrenal insufficiency in asymptomatic adrenoleukodystrophy patients identified by very long-chain fatty acid screening. J Pediatr. 2005 Apr;146(4):528-32.
Loes DJ, Fatemi A, Melhem ER, Gupte N, Bezman L, Moser HW, Raymond GV Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy. Neurology. 2003 Aug 12;61(3):369-74.
van Geel BM, Bezman L, Loes DJ, Moser HW, Raymond GV. Evolution of phenotypes in adult male patients with X-linked adrenoleukodystrophy. Ann Neurol 2001 Feb;49(2):186-94
Schmidt S, Haase CG, Bezman L, Moser H, Schmidt M, Kohler W, Linington C, Klockgether T. Serum autoantibody responses to myelin oligodendrocyte glycoprotein and myelin basic protein in X-linked adrenoleukodystrophy and multiple sclerosis. J Neuroimmunology 2001 Sep 3;119(1):88-94
Bezman L, Moser AB, Raymond GV, Rinaldo P, Watkins PA, Smith KD, Kass NE, Moser HW. Adrenoleukodystrophy: incidence, new mutation rate, and results of extended family screening. Ann Neurol 2001 Apr;49(4):512-7. |
